Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

George Rodrigues, Cary Oberije, Suresh Senan, Kayoko Tsujino, Terry Wiersma, Marta Moreno-Jimenez, Tae Hyun Kim, Lawrence B. Marks, Ramesh Rengan, Luigi De Petris, Sara Ramella, Kim DeRuyck, Núria Rodriguez De Dios, Andrew Warner, Jeffrey D. Bradley, David A. Palma

    Research output: Contribution to journalArticlepeer-review

    17 Scopus citations

    Fingerprint

    Dive into the research topics of 'Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Physics & Astronomy